New call-to-action
New call-to-action
New call-to-action

FPWR Research Team Presents Latest Grants for PWS Studies [VIDEO]

In this video, FPWR research staff describe the PWS studies that the Foundation has funded in 2017 to eliminate the challenges of Prader-Willi syndrome.

On June 23, FPWR research staff members Theresa Strong and Jessica Bohonowych presented a webinar reviewing recent initiatives funded through FPWR. The webinar is available on video below. It includes an overview of newly funded studies, new opportunities and advances in PWS research.

Research funded in 2017 supports FPWR's five-year research plan, with the goal of eliminating the challenges of PWS through the advancement of research. Their presentation briefly reviews research to date since 2004, and then focuses on studies in progress that were initiated in 2017, including nine studies with grants totalling $800,000:

  • Proof of Concept Study of Vagus Nerve Stimulation From An External Device In PWS (Year 2), Tony Holland, MRCP, University of Cambridge
  • Transcranial Direct Current Stimulation, Startle Modulation and Event-related Potentials of the Brain (year 2), Merlin Butler, PhD, University of Kansas Medical Center
  • Role of the Endocannabinoid System in PWS-Induced Osteoporosis and Skeletal Growth, Yossi Tam, DMD, PhD, Hebrew University of Jerusalem
  • Prevalence and Aetiology of PWS Low Level Mosaicism In UPD Undetected By Standard Testing, David Godler, PhD, Murdoch Children’s Research Institute
  • Developing Objective Biomarkers of Hyperphagia In Children With PWS, Alexandra Key, PhD, Vanderbilt University
  • A Post-Mortem Study of von Economo Neurons In the Frontal Cortex of Brains of Persons With PWS (year 2), Patrick Hof, MD, Icahn School of Medicine at Mount Sinai
  • Gene Expression Analysis in PWS Subject Derived Dental Pulp Stem Cell Neurons (year 2), Lawrence Reiter, PhD, University of Tennessee Health Sciences
  • Therapeutic Potential of Blocking Zinc Finger Protein 374 Binding to the PWS Locus, Marc LaLande, PhD, University of Connecticut
  • Evaluating Factors That May Affect the Efficacy of Intranasal Oxytocin Treatment in PWS. Daniel Driscoll, MD, PhD, University of Florida

To hear FPWR's research team describe these studies, watch the video below. This blog also provides a brief overview of PWS studies funded by FPWR in 2017.

 

 

Understanding PWS - Slide Deck

Topics: Research

Susan Hedstrom

author-image

Susan Hedstrom is the Executive Director for the Foundation for Prader-Willi Research. Passionate about finding treatments for PWS, Susan joined FPWR in 2009 shortly after her son, Jayden, was diagnosed with Prader-Willi Syndrome. Rather than accepting PWS as it has been defined, Susan has chosen to work with a team of pro-active and tireless individuals to accelerate PWS research in order to change the future of PWS. Inspired by her first FPWR conference and the team of researchers that were working to find answers for the syndrome, she joined the FPWR team in 2010 and led the development of the One SMALL Step walk program. Under Susan’s leadership, over $15 million has been raised for PWS related research.